JBIO
NASDAQ
$19.67
Jade Biosciences Inc (JBIO)
Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $48.50 (+146.57%)
Market Cap
$1.08B
Free Cash Flow Yield
-10.81%
Beta (5Y)
0.53
Price Chart
Valuation
Market Cap$1.08B
P/B4.38
Profitability
EBITDA-$134M
EPS-$3.22
Financial Health
Free Cash Flow Yield-10.81%
Growth & Risk
Beta (5Y)0.53
Sharpe Ratio1.28